Daily medication use in nursing home residents with advanced dementia

Journal of the American Geriatrics Society

Volumn 58, Issue 5, 2010, Pages 880-888

  Tjia, Jennifer ^a   Rothman, Margaret R ^b   Kiely, Dan K ^c   Shaffer, Michele L ^d   Holmes, Holly M ^e   Sachs, Greg A ^f,g   Mitchell, Susan L ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

^c Hebrew SeniorLife Institute for Aging Research   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f Division of General Internal Medicine and Geriatrics   (United States)

^g INDIANA UNIVERSITY   (United States)

Author keywords

Dementia; End of life care; Inappropriate medication use; Nursing homes; Polypharmacy

Indexed keywords

AMFEBUTAMONE; ANALGESIC AGENT; ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE; CALCIUM; CARDIOVASCULAR AGENT; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; DIGOXIN; DIURETIC AGENT; ESTROGEN; GASTROINTESTINAL AGENT; HEMATOLOGIC AGENT; HYDRALAZINE; HYPNOTIC AGENT; MEMANTINE; MIRTAZAPINE; NEUROLEPTIC AGENT; NOOTROPIC AGENT; RALOXIFENE; RESPIRATORY TRACT AGENT; SCOPOLAMINE; THYROID HORMONE; UNINDEXED DRUG; WARFARIN;

ACUTE DISEASE; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; COGNITION; DEMENTIA; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; GERIATRIC CARE; HOSPICE CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME PATIENT; PRESCRIPTION; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; TERMINAL CARE; COHORT ANALYSIS; MEDICATION COMPLIANCE; NURSING HOME; POLYPHARMACY; PROSPECTIVE STUDY; VERY ELDERLY;

AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CHOLINESTERASE INHIBITORS; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; MALE; MEDICATION ADHERENCE; NURSING HOMES; POLYPHARMACY; PROSPECTIVE STUDIES; TERMINAL CARE;

EID: 77952146793     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02819.x     Document Type: Article

References (29)

1. Magaziner J, German P, Zimmerman SI et al. The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: Diagnosis by expert panel. Epidemiology of Dementia in Nursing Homes Research Group. Gerontologist 2000 40:663 672.
2. Gruber-Baldini AL, Stuart B, Zuckerman IH et al. Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries. J Am Geriatr Soc 2007 55:1508 1516. (Pubitemid 47508513)
3. Bynum JP, Rabins PV, Weller W et al. The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use. J Am Geriatr Soc 2004 52:187 194. (Pubitemid 38233479)
4. Doshi JA, Shaffer T, Briesacher BA. National estimates of medication use in nursing homes: Findings from the 1997 Medicare Current Beneficiary Survey and the 1996 Medical Expenditure Survey. J Am Geriatr Soc 2005 53:438 443. (Pubitemid 41623522)
5. Beers MH, Ouslander JG, Fingold SF et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992 117:684 689.
6. Luchins DJ, Hanrahan P. What is appropriate health care for end-stage dementia? J Am Geriatr Soc 1993 41:25 30. (Pubitemid 23018046)
7. Gurwitz JH, Field TS, Judge J et al. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005 118:251 258. (Pubitemid 40312636)
8. Brauner DJ, Muir JC, Sachs GA. Treating nondementia illnesses in patients with dementia. JAMA 2000 283:3230 3235.
9. Field TS, Gurwitz JH, Avorn J et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001 161:1629 1634. (Pubitemid 32681144)
10. Currow DC, Stevenson JP, Abernethy AP et al. Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007 55:590 595.
11. Holmes HM, Hayley DC, Alexander GC et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006 166:605 609.
12. Lee SP, Bain KT, Maio V. Appropriate discontinuation of medications at the end of life: A need to establish consensus criteria. Am J Med Qual 2007 22:393 394.
13. Bain KT, Holmes HM, Beers MH et al. Discontinuing medications: A novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 2008 56:1946 1952.
14. Currow D, Abernethy AP. A framework for managing comorbid conditions in palliative care. J Palliat Med 2006 9:620. (Pubitemid 43938835)
15. Blass DM, Black BS, Phillips H et al. Medication use in nursing home residents with advanced dementia. Int J Geriatr Psychiatry 2008 23:490 496. (Pubitemid 351722109)
16. Holmes HM, Sachs GA, Shega JW et al. Integrating palliative medicine into the care of persons with advanced dementia: Identifying appropriate medication use. J Am Geriatr Soc 2008 56:1306 1311.
17. Weschules DJ, Maxwell TL, Shega JW. Acetylcholinesterase inhibitor and N-methyl-d-aspartic acid receptor antagonist use among hospice enrollees with a primary diagnosis of dementia. J Palliat Med 2008 11:738 745.
18. Mitchell SL, Kiely DK, Jones RN et al. Advanced dementia research in the nursing home: The CASCADE study. Alzheimer Dis Assoc Disord 2006 20:166 175.
19. Morris JN, Fries BE, Mehr DR et al. MDS Cognitive Performance Scale. J Gerontol 1994 49:M174 M182.
20. Reisberg B, Ferris SH, de Leon MJ et al. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982 139:1136 1139. (Pubitemid 12051593)
21. Albert M, Cohen C. The test for severe impairment: An instrument for the assessment of patients with severe cognitive dysfunction. J Am Geriatr Soc 1992 40:449 453.
22. Volicer L, Hurley AC, Lathi DC et al. Measurement of severity in advanced Alzheimer's disease. J Gerontol 1994 49:M223 M226. (Pubitemid 24282305)
23. D'Agata E, Mitchell SL. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med 2008 168:357 362. (Pubitemid 351347126)
24. Hilbe J. Negative Binomial Regression.
25. Tariot PN, Farlow MR, Grossberg GT et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: A randomized controlled trial. JAMA 2004 291:317 324. (Pubitemid 38101604)
26. Schneider LS, Tariot PN, Dagerman KS et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 2006 355:1525 1538. (Pubitemid 44547805)
27. Gill SS, Bronskill SE, Normand SL et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007 146:775 786. (Pubitemid 351650498)
28. Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ 2008 336:2 3.
29. Grimmsman T, Schwabe U, Himmel W. The influence of hospitalization on drug prescription in primary care - a large-scale follow-up study. Eur J Clin Pharm 2007 63:783 790. (Pubitemid 47052053)